Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of immune responses in gene/stem cell therapies for muscular dystrophies.

BioMed research international - 1 Jan 2014

Farini Andrea, Sitzia Clementina, Erratico Silvia, Meregalli Mirella, Torrente Yvan

Abstract excerpt

Muscular dystrophies (MDs) are a heterogeneous group of diseases, caused by mutations in different components of sarcolemma, extracellular matrix, or enzymes. Inflammation and innate or adaptive immune response activation are prominent features of MDs. Various therapies under development are directed toward rescuing the dystrophic muscle damage using gene transfer or cell therapy. Here we discussed current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell- and Tissue-Based Therapy
Share to Extracellular Matrix

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Immunity, Innate

Share to Muscular Dystrophies

Share to Mutation

Share to Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 24959590
DOI: 10.1155/2014/818107
PMCID: PMC4052166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of immune responses in gene/stem cell therapies for muscular dystrophies.PMID 24959590Read ↗

The immune system in Duchenne muscular dystrophy: Friend or foeSemantic proximity Read ↗

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammationSemantic proximity Read ↗

Stem Cell Transplantation for Muscular Dystrophy: The Challenge of Immune ResponseSemantic proximity Read ↗

Immunobiology of Inherited Muscular DystrophiesSemantic proximity Read ↗

Molecular and cell-based therapies for muscle degenerations: a road under constructionSemantic proximity Read ↗

Problems and solutions in myoblast transfer therapySemantic proximity Read ↗

Muscular dystrophy: new challenges and review of the current clinical trials.Semantic proximity Read ↗

Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case reportSemantic proximity Read ↗

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.Semantic proximity Read ↗

Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human TrialsSemantic proximity Read ↗

Systemic cell therapy for muscular dystrophiesSemantic proximity Read ↗

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.